Last reviewed · How we verify
Prone hyperpolarized 3 helium gas scan — Competitive Intelligence Brief
marketed
Pulmonology / Respiratory
Small molecule
Live · refreshed every 30 min
Target snapshot
Prone hyperpolarized 3 helium gas scan (Prone hyperpolarized 3 helium gas scan) — Eric A. Hoffman. Hyperpolarized helium-3 gas imaging is a diagnostic imaging technique that uses polarized helium-3 gas inhaled by patients to visualize lung ventilation and detect regional ventilation defects.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Prone hyperpolarized 3 helium gas scan TARGET | Prone hyperpolarized 3 helium gas scan | Eric A. Hoffman | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Prone hyperpolarized 3 helium gas scan CI watch — RSS
- Prone hyperpolarized 3 helium gas scan CI watch — Atom
- Prone hyperpolarized 3 helium gas scan CI watch — JSON
- Prone hyperpolarized 3 helium gas scan alone — RSS
Cite this brief
Drug Landscape (2026). Prone hyperpolarized 3 helium gas scan — Competitive Intelligence Brief. https://druglandscape.com/ci/prone-hyperpolarized-3-helium-gas-scan. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab